National Research Corporation (NRC)

Revance Therapeutics Market Cap

National Research has a market cap or net worth of $290.64 million as of August 1, 2025. Its market cap has decreased by -50.46% in one year.

• Market Cap: 290.64M
• Enterprise Value: 366.33M
• 1-Year Change: -50.46%
• Ranking: #3398
• Category: Micro-Cap
• Stock Price: $12.52

Market Cap Chart

Since December 1, 1998, National Research's market cap has increased from $43.70M to $290.64M, an increase of 565.09%. That is a compound annual growth rate of 7.36%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	286.60M	-30.79%
Dec 31, 2024	414.10M	-57.38%
Dec 29, 2023	971.50M	5.48%
Dec 30, 2022	921.00M	-12.83%
Dec 31, 2021	1.06B	-2.32%
Dec 31, 2020	1.08B	-34.17%
Dec 31, 2019	1.64B	73.99%
Dec 31, 2018	944.40M	-32.45%
Dec 29, 2017	1.40B	33.39%
Dec 30, 2016	1.05B	36.40%
Dec 31, 2015	768.40M	20.06%
Dec 31, 2014	640.00M	-26.24%
Dec 31, 2013	867.70M	133.57%
Dec 31, 2012	371.50M	42.34%
Dec 30, 2011	261.00M	14.32%
Dec 31, 2010	228.30M	65.55%
Dec 31, 2009	137.90M	-28.88%
Dec 31, 2008	193.90M	3.58%
Dec 31, 2007	187.20M	19.69%
Dec 29, 2006	156.40M	28.83%
Dec 30, 2005	121.40M	4.93%
Dec 31, 2004	115.70M	-1.78%
Dec 31, 2003	117.80M	72.73%
Dec 31, 2002	68.20M	54.30%
Dec 31, 2001	44.20M	57.30%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	664.39B
Johnson & Johnson	396.75B
AbbVie	333.89B
AstraZeneca	232.21B
UnitedHealth Group	226.39B
Novartis AG	224.47B
Abbott Laboratories	219.63B
Novo Nordisk	213.92B